Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Future Of TG’s Ukoniq In Question As Drug Attracts Closer FDA Scrutiny
Feb 03 2022
•
By
Alaric DeArment
TG's Ukoniq has come under increased FDA scrutiny over its safety-efficacy profile • Source: Shutterstock
More from Anticancer
More from Therapeutic Category